{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:55:23Z","timestamp":1772852123981,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127332","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:19:06Z","timestamp":1749446346000},"page":"127332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cost-effectiveness of pentavalent meningococcal (MenABCWY) vaccination among adolescents in the United States"],"prefix":"10.1016","volume":"61","author":[{"given":"Xiaoyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah F.","family":"Schillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Alexandra","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Leidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127332_bb0005","series-title":"Centers for Disease Control and Prevention Meningococcal disease symptoms and complications","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127332_bb0010","series-title":"Meningococcal Disease. The epidemiology and prevention of vaccine-preventable diseases","author":"Mbaeyi","year":"2021"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127332_bb0020","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127332_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"15","key":"10.1016\/j.vaccine.2025.127332_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.15585\/mmwr.mm7315a4","article-title":"Use of the Pfizer pentavalent meningococcal vaccine among persons aged >\/=10 years: recommendations of the advisory committee on immunization practices - United States, 2023","volume":"73","author":"Collins","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127332_bb0040","article-title":"GRADE\/evidence to recommendations framework (EtR) for GSK pentavalent (MenABCWY) vaccine","author":"Schillie","year":"2024","journal-title":"Published"},{"key":"10.1016\/j.vaccine.2025.127332_bb0050","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance. Published 2024. Accessed November 11, 2024. Available at: https:\/\/www.cdc.gov\/abcs\/index.html."},{"key":"10.1016\/j.vaccine.2025.127332_bb0065","unstructured":"Pfizer Trumenba package insert. Published 2018. Accessed November 22, 2024. Available at:. https:\/\/www.fda.gov\/media\/89936\/download."},{"issue":"2","key":"10.1016\/j.vaccine.2025.127332_bb0070","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine","volume":"139","author":"Cohn","year":"2017","journal-title":"Pediatrics"},{"issue":"42","key":"10.1016\/j.vaccine.2025.127332_bb0075","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1016\/j.vaccine.2019.08.065","article-title":"MenACWY-CRM conjugate vaccine booster dose given 4-6\u00a0years after priming: results from a phase IIIb, multicenter, open label study in adolescents and adults","volume":"37","author":"Tipton","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127332_bb0080","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/INF.0000000000000438","article-title":"Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescents","volume":"33","author":"Baxter","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127332_bb0085","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1080\/21645515.2020.1733867","article-title":"Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a phase III randomized study","volume":"16","author":"Anez","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127332_bb0090","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.4161\/hv.25505","article-title":"Persistence of antibodies in adolescents 18-24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine","volume":"9","author":"Santolaya","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127332_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14760584.2019.1580579","article-title":"Optimizing the timing of 4CMenB vaccination in adolescents and young adults based on immune persistence and booster response data","volume":"18","author":"Watson","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127332_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2206433","article-title":"Effectiveness of a meningococcal group B vaccine (4CMenB) in children","volume":"388","author":"Castilla","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127332_bb0105","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1080\/21645515.2021.1968214","article-title":"Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses - results from two phase 2b randomized trials in adolescents","volume":"17","author":"Vesikari","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"33","key":"10.1016\/j.vaccine.2025.127332_bb0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.15585\/mmwr.mm7333a1","article-title":"National Vaccination Coverage among Adolescents Aged 13-17 years - National Immunization Survey-Teen, United States, 2023","volume":"73","author":"Pingali","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127332_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/524041","article-title":"Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States","volume":"46","author":"Ortega-Sanchez","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127332_bb0120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/13696998.2018.1542520","article-title":"Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations","volume":"22","author":"Grosse","year":"2019","journal-title":"J Med Econ"},{"key":"10.1016\/j.vaccine.2025.127332_bb0125","unstructured":"Ortega-Sanchez I.R. The cost-effectiveness of a potential pentavalent meningococcal conjugate vaccine (men ABCWY) versus the current men ACWY and men B vaccines for US adolescents. Published 2023. Accessed 22 November 2024. Available at: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-06-21-23\/02-Mening-Ortega-Sanchez-508.pdf."},{"key":"10.1016\/j.vaccine.2025.127332_bb0130","series-title":"U.S. Bureau of Labor Statistics. Consumer price index for all urban consumers (CPI-U): medical care","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127332_bb0135","series-title":"Federal Reserve Bank. Gross domestic product: implicit price deflator","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127332_bb0140","series-title":"Centers for Disease Control and Prevention. Current CDC vaccine price list","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127332_bb0145","unstructured":"2022 Merative MarketScan data publication and trademark guidelines."},{"issue":"3","key":"10.1016\/j.vaccine.2025.127332_bb0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11136-020-02650-y","article-title":"US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples","volume":"30","author":"Jiang","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.vaccine.2025.127332_bb0155","series-title":"Prevention effectiveness: A guide to decision analysis and economic evaluation. 2nd ed. New York","author":"Haddix","year":"2003"},{"key":"10.1016\/j.vaccine.2025.127332_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126667","article-title":"Trends in costs of routinely recommended vaccines in the United States, 2001-2023","volume":"47","author":"Kaul","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127332_bb0165","author":"Dong"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127332_bb0170","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/07448481.2017.1312418","article-title":"Safety of a meningococcal group B vaccine used in response to two university outbreaks","volume":"65","author":"Duffy","year":"2017","journal-title":"J Am Coll Heal"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127332_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40272-024-00666-2","article-title":"Meningococcal vaccination in the United States: past, present","volume":"27","author":"Schillie","year":"2025","journal-title":"And Future Paediatr Drugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T21:25:05Z","timestamp":1755897905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S0264410X25006292"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127332","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of pentavalent meningococcal (MenABCWY) vaccination among adolescents in the United States","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127332"}}